ILLUMINA MISEQDX CYSTIC FIBROSIS CLINICAL SEQUENCING ASSAY

System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Variant Gene Sequence Detection

ILLUMINA, INC.

The following data is part of a premarket notification filed by Illumina, Inc. with the FDA for Illumina Miseqdx Cystic Fibrosis Clinical Sequencing Assay.

Pre-market Notification Details

Device IDK132750
510k NumberK132750
Device Name:ILLUMINA MISEQDX CYSTIC FIBROSIS CLINICAL SEQUENCING ASSAY
ClassificationSystem, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Variant Gene Sequence Detection
Applicant ILLUMINA, INC. 5200 ILLUMINA WAY San Diego,  CA  92122
ContactBryan Schneider
CorrespondentBryan Schneider
ILLUMINA, INC. 5200 ILLUMINA WAY San Diego,  CA  92122
Product CodePFS  
CFR Regulation Number866.5900 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2013-09-03
Decision Date2013-11-19
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00816270020026 K132750 000
00816270020385 K132750 000
00816270020262 K132750 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.